Researchers from the MRC Toxicology Unit attended last week’s British Toxicology Society (BTS) Congress in Solihull, a key annual event that brings together experts from across toxicology and safety science, spanning academia, industry, and regulatory sectors. The meeting provided an excellent platform for early career...

Dr Ritwick Sawarkar, Group Leader at the MRC Toxicology Unit, alongside Dr Kadri Seppa, a Postdoctoral Researcher in the lab, have been awarded €150,000 from the European Research Council (ERC) to develop a novel mRNA therapeutic approach to treat Alzheimer's disease. Dementia affected 55 million people in 2020, and cases...

The conference marked the inaugural event of the UK Proteostasis Network , an initiative launched by the Babraham Institute and shaped by Network Coordinators: Ritwick Sawarkar from the MRC Toxicology Unit, Della David and Oliver Florey at the Babraham Institute, and Laura Itzhaki at the University of Cambridge.

We all go through times when we are not on track, feeling a little blue and out of our usual form. These are the times when we need a little warmth from those close to us – some extra support, a helping hand. The same goes for the proteins in our cells. Proteins are the workhorses in our cells and have numerous tasks to...

We are delighted to share the news that Prof Anne Willis and Dr Ritwick Sawarkar are a part of a consortium that has been awarded £8 million by the Nucleic Acid Therapy Accelerator (NATA) to enhance the UK's nucleic acid therapeutics delivery platforms. The consortium, led by Professor Matthew Wood at the University of...

Roberto Campalastri, a PhD student in Ritwick Sawarkar's group, won the prestigious Gates Trust Scholarship . In his future research he will focus on the identification of novel cis-and trans- regulatory elements of human RNA Polymerase III by using artificial intelligence (AI) methods and genomic tools.

Andres Herrero was awarded by both the EMBO Postdoctoral and the Marie Sklodowska-Curie Postdoctoral Fellowships. He aims to understand the regulation of human RNA Polymerase III by combining high-throughput sequencing, experimental, and computational approaches.